#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
Historically, children with chronic hepatitis B would be treated with one of two drugs, interferon and lamivudine. There are other medications – adefovir, entecavir, and peginterferon – that the Food and Drug Administration has approved for treating chronic hepatitis B in adolescents and adults. Maureen Jonas, MD, director of the Center for Childhood Liver Disease at Boston Children's Hospital, is studying these medications in children, with the goal of encouraging the FDA to approve their use more broadly in children with chronic hepatitis B.
Liver biopsies provide a great deal of information about how much hepatitis B and/or other conditions have damaged a child’s liver. But the process of taking a biopsy is invasive, can be painful, and is not without risk. Dr. Jonas and colleagues are also investigating an ultrasound-based imaging technology called Fibroscan, which may be able to help doctors assess a child’s liver scarring through a virtual biopsy.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”